These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38753759)

  • 1. WLB-87848, a Selective σ
    Christmann U; Garriga L; Llorente AV; Díaz JL; Pascual R; Bordas M; Dordal A; Porras M; Yeste S; Reinoso RF; Vela JM; Almansa C
    J Med Chem; 2024 Jun; 67(11):9150-9164. PubMed ID: 38753759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of WLB-89462, a New Drug-like and Highly Selective σ
    Christmann U; Díaz JL; Pascual R; Bordas M; Álvarez I; Monroy X; Porras M; Yeste S; Reinoso RF; Merlos M; Vela JM; Almansa C
    J Med Chem; 2023 Sep; 66(17):12499-12519. PubMed ID: 37607512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments.
    Maurice T
    Behav Brain Res; 2016 Jan; 296():270-278. PubMed ID: 26386305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sigma-1 (σ₁) receptor deficiency reduces β-amyloid(25-35)-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B.
    Yin J; Sha S; Chen T; Wang C; Hong J; Jie P; Zhou R; Li L; Sokabe M; Chen L
    Neuropharmacology; 2015 Feb; 89():215-24. PubMed ID: 25286118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain.
    Lan Y; Chen Y; Cao X; Zhang J; Wang J; Xu X; Qiu Y; Zhang T; Liu X; Liu BF; Zhang G
    J Med Chem; 2014 Dec; 57(24):10404-23. PubMed ID: 25420090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sigma-1 Receptor Agonists Induce Oxidative Stress in Mitochondria and Enhance Complex I Activity in Physiological Condition but Protect Against Pathological Oxidative Stress.
    Goguadze N; Zhuravliova E; Morin D; Mikeladze D; Maurice T
    Neurotox Res; 2019 Jan; 35(1):1-18. PubMed ID: 29127580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer's disease.
    Lahmy V; Meunier J; Malmström S; Naert G; Givalois L; Kim SH; Villard V; Vamvakides A; Maurice T
    Neuropsychopharmacology; 2013 Aug; 38(9):1706-23. PubMed ID: 23493042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sigma-1 receptor in brain ischemia/reperfusion: Possible role in the NR2A-induced pathway to regulate brain-derived neurotrophic factor.
    Xu Q; Ji XF; Chi TY; Liu P; Jin G; Chen L; Zou LB
    J Neurol Sci; 2017 May; 376():166-175. PubMed ID: 28431607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of high affinity Σ1 receptor selective compounds.
    Luedtke RR; Perez E; Yang SH; Liu R; Vangveravong S; Tu Z; Mach RH; Simpkins JW
    Brain Res; 2012 Mar; 1441():17-26. PubMed ID: 22285434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-amnesic effect of neurosteroid PREGS in Aβ25-35-injected mice through σ1 receptor- and α7nAChR-mediated neuroprotection.
    Yang R; Chen L; Wang H; Xu B; Tomimoto H; Chen L
    Neuropharmacology; 2012 Nov; 63(6):1042-50. PubMed ID: 22884465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-amnesic and neuroprotective actions of the sigma-1 receptor agonist (-)-MR22 in rats with selective cholinergic lesion and amyloid infusion.
    Antonini V; Marrazzo A; Kleiner G; Coradazzi M; Ronsisvalle S; Prezzavento O; Ronsisvalle G; Leanza G
    J Alzheimers Dis; 2011; 24(3):569-86. PubMed ID: 21297260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of a new series of hexahydro-2H-pyrano[3,2-c]quinolines as novel selective σ1 receptor ligands.
    Díaz JL; Christmann U; Fernández A; Luengo M; Bordas M; Enrech R; Carro M; Pascual R; Burgueño J; Merlos M; Benet-Buchholz J; Cerón-Bertran J; Ramírez J; Reinoso RF; Fernández de Henestrosa AR; Vela JM; Almansa C
    J Med Chem; 2013 May; 56(9):3656-65. PubMed ID: 23560650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydroepiandrosterone administration improves memory deficits following transient brain ischemia through sigma-1 receptor stimulation.
    Yabuki Y; Shinoda Y; Izumi H; Ikuno T; Shioda N; Fukunaga K
    Brain Res; 2015 Oct; 1622():102-13. PubMed ID: 26119915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of novel 6,7-dihydro-5H-cyclopenta[d]pyrimidine and 5,6,7,8-tetrahydroquinazoline derivatives as sigma-1 (σ1) receptor antagonists for the treatment of pain.
    Lan Y; Songyang Y; Zhang L; Peng Y; Song J
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2051-6. PubMed ID: 26947609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of Esaprazole analogues showing σ1 binding and neuroprotective properties in vitro.
    Kelly NM; Wellejus A; Elbrønd-Bek H; Weidner MS; Jørgensen SH
    Bioorg Med Chem; 2013 Jun; 21(11):3334-47. PubMed ID: 23601816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives: novel, potent and selective sigma1 receptor ligands.
    Ucar H; Cacciaguerra S; Spampinato S; Van derpoorten K; Isa M; Kanyonyo M; Poupaert JH
    Eur J Pharmacol; 1997 Sep; 335(2-3):267-73. PubMed ID: 9369382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEPO-Fc (An EPO Derivative) Protects Hippocampus Against Aβ-induced Memory Deterioration: A Behavioral and Molecular Study in a Rat Model of Aβ Toxicity.
    Hooshmandi E; Motamedi F; Moosavi M; Katinger H; Zakeri Z; Zaringhalam J; Maghsoudi A; Ghasemi R; Maghsoudi N
    Neuroscience; 2018 Sep; 388():405-417. PubMed ID: 30102955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives.
    Franchini S; Battisti UM; Prandi A; Tait A; Borsari C; Cichero E; Fossa P; Cilia A; Prezzavento O; Ronsisvalle S; Aricò G; Parenti C; Brasili L
    Eur J Med Chem; 2016 Apr; 112():1-19. PubMed ID: 26874044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway.
    Canas PM; Porciúncula LO; Cunha GM; Silva CG; Machado NJ; Oliveira JM; Oliveira CR; Cunha RA
    J Neurosci; 2009 Nov; 29(47):14741-51. PubMed ID: 19940169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid toxicity is enhanced after pharmacological or genetic invalidation of the σ
    Maurice T; Strehaiano M; Duhr F; Chevallier N
    Behav Brain Res; 2018 Feb; 339():1-10. PubMed ID: 29129596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.